Clinical Trial Update: 68Ga-P16-093 PET/CT Imaging in Glioma Patients [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on 68Ga-P16-093 PET/CT imaging in glioma patients across Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioma

Drugs mentioned

• 68Ga-P16-093 (P16-093 Ga-68 radiopharmaceutical)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Glioma | Phase 1, Phase 2 | Status: UNKNOWN